Creative Biolabs Announces Complement Testing Services

Creative Biolabs has made new complement function activity testing and hemolytic inhibition assays available to enable therapeutics and immunology research breakthroughs.
New York, USA - March 20, 2025 - The research of complement therapeutics faces great challenges, including the complexity of the complement system, the need for consistent and reproducible assays, and, most importantly, the lack of standardized testing methods. Creative Biolabs, a life science biotech firm focused on developing competitive solutions, announced the launch of its broad range of complement testing [https://www.creative-biolabs.com/complement-therapeutics/complement-testing-services.htm] services. These various services aim to help researchers and pharmaceutical companies in the continuous discovery of the complement system and assist the rapid development of next-generation medicines.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

These new offerings cover complement function activity testing [https://www.creative-biolabs.com/complement-therapeutics/complement-function-activity-test.htm], hemolytic inhibition tests [https://www.creative-biolabs.com/complement-therapeutics/hemolytic-inhibition-assay.htm], and many other custom assays that cater to the diverse needs of the scientific community. With these services, users can expect precise, reproducible, high-throughput assays for the determination of complement system activity that are imperative to research in autoimmune disease, infectious disease, and cancer immunotherapy.

"The complement system is a key regulator of immune function and pathogenesis, so it is an ideal target for therapeutic intervention," says a lead researcher at Creative Biolabs. The new complement testing services have been designed to provide every researcher with an instrument that helps them explore the potential of complement-targeted therapies and diagnostics.

Major Features of the New Services:

* Complement Function/Activity Assay Testing: Enables the determination of complement pathway activity, providing information regarding the functional integrity of the complement system. Creative Biolabs is able to provide a wide range of high-quality complement function or activity tests utilizing human and animal serums.

* Hemolytic Inhibition Assay: Rapid assessments of complement activity can easily be done using the custom hemolytic inhibition assays. For the samples that are not suitable for mailing, this company also provide ready-to-use hemolytic assay products and guidance.

Complement testing services at Creative Biolabs have the backing of state-of-the-art technology, experienced scientists, and a commitment to the delivery of high-quality data. Most importantly, these services will dramatically reduce the time and expense of complement research.

For more information on the complement testing services at Creative Biolabs, visit https://www.creative-biolabs.com/complement-therapeutics.

About Creative Biolabs

Creative Biolabs is a company devoted to advancing life sciences and biotechnology with innovative solutions and peerless experience. Many solutions, from complement tests to complement component inhibitor development, help researchers and institutions achieve their therapeutic and scientific goals.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-announces-complement-testing-services]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/complement-therapeutics

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.